Molecular Transducers of Physical Activity Consortium (MoTrPAC)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

320 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-22

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the Molecular Transducers of Physical Activity Consortium (MoTrPAC) is to assess molecular changes that occur in response to physical activity (PA). To achieve this aim, studies will be conducted in adults and separately in children and adolescents. The UC Irvine MoTrPAC Pediatric Clinical Center oversees two interrelated study phases in children and adolescents:

1. A cross-sectional phase in which molecular transducers (obtained from blood sampling) are measured in response to an acute exercise challenge (n = 320);
2. An intervention phase is conducted as a mechanistic randomized controlled trial (RCT). Participants are recruited from the cross-sectional study phase and randomized to endurance exercise (EE) training (n = 120) or no exercise Control (n = 50) for a period of approximately 12 weeks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Molecular Transducers of Physical Activity Consortium

NCT03960827

Physical Activity

COMPLETED NA

Efficacy of Increasing Physical Activity to Reduce Children's Visceral Fat

NCT00359957

Obesity

COMPLETED PHASE1/PHASE2

The Impact of Resistance Exercise Training On Metabolic Dysregulation in Obese Children.

NCT00460135

Childhood Obesity Body Composition Resistance Training +1 more

COMPLETED NA

Effectiveness of a Physical Activity Intervention on Preventing Obesity During the Adiposity Rebound Period.

NCT01971840

Physical Activity Adiposity Children +2 more

UNKNOWN NA

Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity

NCT01580319

Obesity Hypercholesterolemia High Blood Pressure +1 more

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The overarching hypothesis is that there are discoverable molecular transducers that communicate and coordinate the effects of exercise on cells, tissues, and organs, which may initiate processes ultimately leading to the health benefits of exercise. Because this is a mechanistic trial, the main goal is not a single health-related outcome. Rather, the goal is to generate a resource leading to the generation of a map of the molecular responses to exercise that will be used by the Consortium and by the scientific community at large to generate hypotheses for future investigations of the health benefits of PA. Study assessments are completed before and after the intervention period (exercise or control), and at specific interim time points during the intervention. An additional focus of the pediatric studies is to examine the impact of sex and developmental phase (self-reported pubertal stage) during childhood and adolescence on acute and chronic exercise responses.

Assessments include measurements of cardiorespiratory fitness, muscular strength, and body composition (including whole body bone mineral content) determined by dual-energy x-ray absorptiometry (DXA). There is also collection of blood, monitoring of free-living PA level using wearable devices, and completion of participant reported outcomes and health status by interview and/or questionnaire. As part of the MoTrPAC functions, participant data and biological samples are transferred from the Pediatric Clinical Site to the Consortium Coordinating Center (CCC) Data Management, Analysis and Quality Control Center (DMAQC) and to the Biological Sample Repository, and later analyzed by the Consortium Chemical Analysis Sites (CAS) and the Bioinformatics Center (BIC).

Biological samples collected in this project undergo molecular phenotyping, including metabolomic, lipidomic, proteomic, epigenomic, transcriptomic, and genomic analyses. These assays are done at the MoTrPAC CAS.

Overall coordination of the study and analyses occurs at 4 institutions which make up the CCC and the BIC.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The randomized trial is conducted in accordance with an intent-to-treat (ITT) design.

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Intervention Control

The control group is randomized but does not participate in the intervention but does complete the acute test and biospecimen collection following the intervention period.

Group Type NO_INTERVENTION

No interventions assigned to this group

Endurance Exercise

Participants randomized to EE participate in the intervention and complete the acute test and biospecimen collection following the intervention period.

Group Type ACTIVE_COMPARATOR

EE Training

Intervention Type OTHER

Participants randomized to EE training engage in three school-based or center-based (PERC) EE training sessions each week for approximately 12 weeks; each session lasting roughly 70 min with a 45-50 minutes of a stimulus phase and the remaining time being used to warm-up and cool down.

Cross Sectional HA

Do not participate in intervention after single acute exercise test of Endurance Exercise.

Group Type NO_INTERVENTION

No interventions assigned to this group

Cross Sectional LA

Do not participate in intervention after single acute exercise test of Endurance Exercise.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EE Training

Participants randomized to EE training engage in three school-based or center-based (PERC) EE training sessions each week for approximately 12 weeks; each session lasting roughly 70 min with a 45-50 minutes of a stimulus phase and the remaining time being used to warm-up and cool down.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parent or legal guardian and participant are willing to provide informed consent and assent to participate in the MoTrPAC Study
* Must be able to read and speak English well enough to provide informed consent, assent and understand instructions
* Children and adolescents ages 10-17 (Pubertal stages 1-5)
* Determined to be in good health by pre-participation medical history review performed at PERC
* BMI %ile (\>5th, \<95th)
* Weight ≥30 Kg (minimum required for blood collection)
* LAEE children defined as self-reported of no more than 2 days per week, lasting no more than 120 minutes per week, of regular (structured) intense endurance exercise (e.g., running, cycling, elliptical, soccer, swimming and rowing activity that results in feelings of substantially increased heart rate and rapid breathing and sweating with limited ability to talk) in the 3 months prior to study enrollment.
* HAEE children in this study is defined as:
* self-reported participation in a structured/regular endurance sports (e.g., running, cycling, soccer, swimming and rowing activity that results in feelings of substantially increased heart rate and rapid breathing and sweating with limited ability to talk).
* Participation in these activities is ≥4 times per week (\>240 min per week) for at least 9 months prior to study enrollment.

Exclusion Criteria

* Self-report or laboratory evidence of familial hyperlipidemia/dyslipidemia (e.g., total cholesterol ≥ 200mg/dL and or triglyceride ≥ 100mg/dL)
* Daily or weekly chronic use of any prescription medication in the past 3 months (excluding birth control)
* Any use of tobacco, e-cigarettes, illegal drugs, alcohol, or marijuana (self-report) within the last 12 months
* Pregnancy or breastfeeding
* Sudden or abrupt (≥5%) weight lost (self-report) over the preceding 3 months
* Past history of serious chronic diseases (including, but not limited to: asthma, diabetes, juvenile idiopathic arthritis, cystic fibrosis, malignancy, congenital heart disease, cerebral palsy, muscular dystrophy, autoimmune diseases, inflammatory bowel disease)
* Evidence of disease, disability or other condition that would impair participation in physical activity as determined by a study clinician
* Blood donation in the past 3 months (self-report)

Minimum Eligible Age

10 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes